Equity

Deferred shares, $0.000001 par value; issued and outstanding: 2026–427,355 and 2025–411,475

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026

How to read this metric

Changes are usually driven by corporate restructuring or specific equity issuance events rather than operational performance.

Detailed definition

This represents the par value of deferred shares issued by the company, typically carrying limited voting or dividend ri...

Peer comparison

This is a highly specific equity instrument; peers may not have an equivalent class of shares, making direct comparison limited.

Metric ID: equity_deferred_shares_value_issued

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Range$0.00$0.00

Frequently Asked Questions

What is Royalty Pharma's deferred shares, $0.000001 par value; issued and outstanding: 2026–427,355 and 2025–411,475?
Royalty Pharma (RPRX) reported deferred shares, $0.000001 par value; issued and outstanding: 2026–427,355 and 2025–411,475 of $0.00 in Q1 2026.
What does deferred shares, $0.000001 par value; issued and outstanding: 2026–427,355 and 2025–411,475 mean?
The total par value of issued deferred shares held by shareholders.